Colin James Thomas, MD

Jonathan A. Baron, Monica Chelius, Gurbani Singh, Michael D. Schad, Melanie Berger, Emeline R. Chong, Colin J. Thomas, Jordan S. Carter, Michael R. Cook, Sunita D. Nasta, Daniel J. Landsburg, Stefan K. Barta, Jakub Svoboda, Stephen J. Schuster, Nikhil Yegya-Raman, Michael J. LaRiviere, John P. Plastaras, Elise A. Chong and Harper Hubbeling Safe Integration of Radiation Therapy with Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas , Clinical Lymphoma Myeloma and Leukemia: 2026

John Sharp, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Lindsey Fitzgerald, Daniel Reef, Andinet Teferra, Timothy J Voorhees, Supriya Gupta, Natalie S Grover, Stefan K Barta, Mazyar Shadman, Narendranath Epperla Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma , Blood Cancer Journal, 16(1): 2026

Colin J Thomas, Caroline S Myers, Jina Chung, Daniel Landsburg, Sunita D Nasta, Jakub Svoboda, Elise A Chong, Stephen J Schuster, Jordan Carter, Michael Cook, Emily Tomasulo, Omar Elghawy, Michael LaRiviere, Harper Hubbeling, John P Plastaras, Alain H Rook, Jennifer Villasenor-Park, Marco Ruella, Ellen Kim, Stefan K Barta Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden , Blood Neoplasia, 3(3): 2026

Michael Schneider, Luca Paruzzo, Federico Stella, Julia Han Noll, Matthew Ho, Victor Babatunde, Bianca Ho, Pooja Devi, Elise A Chong, Stefan K Barta, Sunita D Nasta, Jakub Svoboda, Jordan Carter, Michael R Cook, Nasheed M Hossain, Colin J Thomas, Vrutti Patel, Vitor B de Souza, Mohannad H Alkhatib, Ziyu Li, Melody Tan, Peter Michener, Puneeth Guruprasad, Antonio Imparato, Alberto Carturan, Patrizia Porazzi, Joseph A Fraietta, Stephen J Schuster, Ivan Maillard, Marco Ruella, Daniel J Landsburg Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy , Nature Communications : 2026

Colin J. Thomas, Ming Jung Koh, Omar Elghawy, et al. Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium , Leukemia & Lymphoma: 2026

John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Daniel Reef, Alexander Micah Gorzewski, John Seng Wang, Geoffrey Shouse, Catherine Reinert, Andinet Teferra, Esteban Toro Velez, Ari Pelcovits, Thomas A Ollila, William Bennett Clark, Victor Yazbeck, Joseph E Maakaron, Manali Kamdar, Lindsey A Fitzgerald, Alexey V Danilov, Reem Karmali, Natalie S Grover, Stefan K Barta, Timothy J Voorhees, Andy I Chen, Mazyar Shadman, Sairah Ahmed, Narendranath Epperla Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study , Blood Advances: 2026

Daniel J Landsburg, Nancy Musoke, Caren Gentile, Taylor R Brooks, Sunita D Nasta, Stefan K Barta, Jordan S Carter, Elise A Chong, Jakub Svoboda, Stephen J Schuster, Colin J Thomas, Emily B Tomasulo, Michael R Cook, Jennifer J D Morrissette, Paolo F Caimi, Brian T Hill Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma , Leukemia: 2026

Adam J Olszewski, Thomas A Ollila, Dai Chihara, Geoffrey Shouse, Natalie Grover, Reem Karmali, Pallawi Torka, Colin Thomas, Praveen Ramakrishnan Geethakumari, Stefan K Barta, Nancy L Bartlett, Narendranath Epperla Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma , Haematologica: 2025

Sharma, M., Myrdal, C., Thomas, C., Chung, J., Barta, S. & Kim, E. A Rare Case of Tender Facial Nodules as a Presenting Sign of Lymphoplasmacytic Lymphoma , JAAD Case Reports, 66: 2025,6:58-61.

Colin J. Thomas & Stefan K. Barta The Promise of Immunotherapies in T-Cell Lymphoma , Clinical Lymphoma, Myeloma & Leukemia, S2152-2650(25): 2025,03399-3.